# Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load

> **NCT01620736** · PHASE2 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- Human T-cell Leukemia Virus Type 1 Infection

## Interventions

- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT01620736
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The clinical trial did not receive any funding.
- **Last updated:** 2018-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01620736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01620736, "Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01620736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*